Medicus Pharma Ltd. Common Stock (MDCX) — Net Asset Momentum

Latest YoY growth as of December 2025: -98.8%

Medicus Pharma Ltd. Common Stock (MDCX) recorded a net asset momentum of -98.8% as of December 2025, with net assets of $37.31K USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Medicus Pharma Ltd. Common Stock net assets for net asset value and shareholders' equity analysis.

YoY Momentum

-98.8%
Year-over-year

Current Net Assets

$37.31K
USD · December 2025

Years of Data

7
2010 – 2025

Country

USA
NASDAQ

Medicus Pharma Ltd. Common Stock Net Asset Momentum (2010–2025)

This chart tracks Medicus Pharma Ltd. Common Stock's year-over-year net asset growth across 7 annual reporting periods from 2010 to 2025. The most recent momentum reading is -98.8%, with net assets of $37.31K USD as of December 2025. For live market cap and overall valuation, see MDCX stock market capitalisation.

Annual Net Asset History for Medicus Pharma Ltd. Common Stock (2010–2025)

The table below shows the complete annual net asset history for Medicus Pharma Ltd. Common Stock from 2010 to 2025, covering 7 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Medicus Pharma Ltd. Common Stock tangible book value ratio to evaluate the tangible quality of the company's equity base.

Year Net Assets (USD) Total Assets Total Liabilities YoY Momentum
2025 $37.31K $10.06 Million $10.02 Million ▼ -98.8%
2024 $3.13 Million $5.65 Million $2.51 Million ▲ +182.0%
2023 $1.11 Million $1.89 Million $781.61K ▲ +109.1%
2022 $-12.20 Million $282.65K $12.48 Million ▼ -16.1%
2021 $-10.51 Million $78.51K $10.58 Million ▼ -16668.5%
2017 $-62.65K $40.58K $103.23K ▲ +96.9%
2010 $-2.00 Million $3.00 Million $5.00 Million